fullerene c60 has been researched along with Lung Neoplasms in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Hsu, SH; Huang, HJ; Kraevaya, OA; Troshin, PA; Voronov, II | 1 |
| Bai, X; Chang, Y; Chen, K; Dong, X; Gu, W; Lei, R; Li, J; Li, S; Ma, S; Qin, Y; Xia, S; Xing, G; Zeng, L; Zhang, J | 1 |
| Hsu, SH; Kraevaya, OA; Mischenko, DV; Troshin, PA; Wong, CW; Zhilenkov, AV | 1 |
| Fang, X; Guan, M; Li, N; Liu, Q; Shu, C; Wang, C; Xu, L; Zhang, X; Zheng, J | 1 |
| Moldoveanu, I; Stanciu Gavan, C; Stefan-van Staden, RI | 1 |
| Doshi, M; Gesquiere, AJ | 1 |
| Chen, C; Fu, PP; Gao, X; Lao, F; Liang, XJ; Meng, J; Sun, B; Wang, PC; Xing, G; Yin, JJ; Zhao, Y | 1 |
| Gilbert, BE; Knight, V; Seryshev, A; Sitharaman, B; Wilson, LJ; Zakharian, TY | 1 |
8 other study(ies) available for fullerene c60 and Lung Neoplasms
| Article | Year |
|---|---|
Fullerene Derivatives as Lung Cancer Cell Inhibitors: Investigation of Potential Descriptors Using QSAR Approaches.
Topics: Cell Death; Cell Line, Tumor; Fullerenes; Humans; Lung Neoplasms; Models, Molecular; Quantitative Structure-Activity Relationship; Solubility; Water | 2020 |
Small size fullerenol nanoparticles suppress lung metastasis of breast cancer cell by disrupting actin dynamics.
Topics: Actin Cytoskeleton; Actins; Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Survival; Elastic Modulus; Female; Fullerenes; Humans; Integrins; Lung Neoplasms; Mice, Nude; Nanoparticles | 2018 |
Toward Understanding the Antitumor Effects of Water-Soluble Fullerene Derivatives on Lung Cancer Cells: Apoptosis or Autophagy Pathways?
Topics: A549 Cells; Animals; Antineoplastic Agents; Apoptosis; Autophagy; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Fullerenes; Humans; Lung Neoplasms; Solubility; Treatment Outcome; Water; Xenograft Model Antitumor Assays; Zebrafish | 2019 |
Enhanced photodynamic efficiency of an aptamer-guided fullerene photosensitizer toward tumor cells.
Topics: Aptamers, Nucleotide; Cell Line, Tumor; Cell Survival; Fullerenes; Humans; Light; Lung Neoplasms; Photochemotherapy; Photosensitizing Agents; Reactive Oxygen Species | 2013 |
Molecular recognition of HER-1 in whole-blood samples.
Topics: Biosensing Techniques; Diamond; ErbB Receptors; Fullerenes; Gastrointestinal Neoplasms; Graphite; Humans; Lung Neoplasms; Nanostructures; Pancreatic Neoplasms | 2014 |
Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers.
Topics: Animals; Cell Line; Cell Line, Tumor; Epithelial Cells; Female; Fullerenes; Humans; Lung Neoplasms; Mice; Nanoparticles; Ovarian Neoplasms; Photochemotherapy; Photosensitizing Agents; Polymers; Vinyl Compounds | 2015 |
Inhibition of tumor growth by endohedral metallofullerenol nanoparticles optimized as reactive oxygen species scavenger.
Topics: Adenocarcinoma; Animals; Cell Line, Tumor; Female; Fullerenes; Gadolinium; Humans; Lipid Peroxidation; Lung Neoplasms; Membrane Potential, Mitochondrial; Mice; Mice, Nude; Mitochondria; Nanostructures; Nanotechnology; Neoplasms; Organometallic Compounds; Oxidative Stress; Oxidoreductases; Reactive Oxygen Species; Time Factors; Tumor Burden; Xenograft Model Antitumor Assays | 2008 |
A fullerene-paclitaxel chemotherapeutic: synthesis, characterization, and study of biological activity in tissue culture.
Topics: Aerosols; Cell Line, Tumor; Cell Proliferation; Drug Delivery Systems; Drug Screening Assays, Antitumor; Fullerenes; Humans; Liposomes; Lung Neoplasms; Molecular Structure; Paclitaxel; Tissue Culture Techniques | 2005 |